Black­stone en­lists a mur­der­ers' row of ad­vi­sors, in­clud­ing ex-Sanofi CEO Olivi­er Brandi­court, to steer life sci­ences biz

Among the biggest in­sti­tu­tion­al in­vestors in the cur­rent biotech craze, Black­stone has been un­afraid to throw its weight around with a ded­i­cat­ed life sci­ences arm plac­ing some hefty bets. Now, hop­ing to get a leg up in ther­a­peu­tics and be­yond, the firm is draft­ing four ex­ec­u­tives with lengthy ré­sumés in­to the fight.

Black­stone Life Sci­ences has fleshed out its se­nior ad­vi­so­ry team with the ap­point­ments of ex-Sanofi CEO and di­rec­tor Olivi­er Brandi­court, NPS Phar­ma vet­er­an Fran­cois Nad­er, for­mer GE Health­care and Medtron­ic CEO Omar Ishrak, and for­mer Ge­nom­ic Health CEO Kim Popovits, the in­vest­ment gi­ant said Tues­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER